Funding for this research was provided by:
Terry Fox Research Institute (Selective Therapy Program)
Fonds de Recherche du Québec-Santé
Ovarian Cancer Canada’s Teal Heart Scholarship
Fonds de Recherche du Québec-Santé Réseau de Recherche sur le cancer
Received: 18 October 2019
Revised: 21 May 2020
Accepted: 21 May 2020
First Online: 8 June 2020
Compliance with ethical standards
: AO is a consultant/advisory board member for Immunogen, AstraZeneca, Tesaro, and Clovis. The other authors declare that they have no conflict of interest.
: Ethical approval for the study was obtained from the Centre hospitalier de l’Université de Montreal (CHUM) institutional ethics committee (Comité d’éthique de la Recherche du CHUM).